FDA's New Acting Commissioner: What is In Store for the Agency?
by Patricia Van Arnum, DCAT Editorial Director
Norman Sharpless, MD, became Acting Commissioner of Food and Drugs for the US Food and Drug Administration (FDA) in early April after taking the helm from FDA Commissioner Scott Gottlieb, who stepped down for personal reasons. With a new executive in, what are the key policy directions for the FDA?Read More
Pharma and Brexit: What Happens Next?
by Patricia Van Arnum, DCAT Editorial Director
The pharmaceutical industry is in a wait-and-see mode as the UK tries to come up with a new Brexit plan that will mend internal division in the UK while still satisfying the EU. What is the impact on supply and pharma regulation? Read More
There will be no issues of DCAT Value Chain Insights on May 22 and May 29. Our next issue is June 5.
DCAT Value Chain Insights: About the Editor
Patricia Van Arnum is Editorial Director at the Drug, Chemical & Associated Technologies Association (DCAT), where she is responsible for delivering informational services for DCAT members. She is editor of two weekly editorial newsletters, DCAT Value Chain Insights and Top Industry News. She also supports DCAT’s volunteer committees and task forces that develop educational programs and informational content for DCAT members. Read More
DCAT Value Chain Insights is produced and distributed by the Drug, Chemical and Associated Technologies Association.
